Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_assertion type Assertion NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_head.
- NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_assertion description "[These observations raise the possibility that application of PEDF may be helpful in designing new therapeutic strategies for neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, Alzheimer's disease and brain ischemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_provenance.
- NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_assertion evidence source_evidence_literature NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_provenance.
- NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_assertion SIO_000772 20236058 NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_provenance.
- NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_assertion wasDerivedFrom befree-2016 NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_provenance.
- NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_assertion wasGeneratedBy ECO_0000203 NP800472.RAtnUwcxqOEPVMGefTg7DlqV50mh6OkiAvF-H1fQ9_lT0130_provenance.